Gut Microbiota: Potential Therapeutic Target for Sickle Cell Disease Pain and Complications.

Tarimoboere Agbalalah Doofan Bur Ezinne Janefrances Nwonu Adekunle Babajide Rowaiye

Published in: Anemia (2024)

Further exploration and clinical trials are needed to harness the full potential of these gut bacteria for individuals affected by this challenging condition.

Keyphrases

sickle cell disease
clinical trial
chronic pain
human health
pain management
randomized controlled trial
risk factors
risk assessment
phase ii
climate change
spinal cord injury
placebo controlled